Skip to main content

Education/ACR/EULAR

EBR Journal Club: Dapirolizumab Pegol in SLE (PHOENYCS GO) The EBR Journal Club Companion applies my adapted JAMA approach to critical appraisal to an important rheumatology RCT. Each review covers four domains: Does this apply to my patients? What is the risk of bias? How https://t.co/kereLii5J6
Dr. John Cush @RheumNow( View Tweet )
“ABCDE” Approach to Difficult-to-Treat Rheumatoid Arthritis The proposed approach to D2T-RA is based on the EULAR definition (having failed 2 or more b/tsDMARDs). It is estimated that up to 20% of RA patients meet this D2T-RA definition and can be plagued by active or https://t.co/o39IREvjI4
Dr. John Cush @RheumNow( View Tweet )

Treating Obesity is Disease-Modifying (9.4.2026)

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com.  New drugs approved, new drugs halted and some drugs out of control. Ready to test your knowlege? Take this week's quiz!

Read Article

ACP Clinical Guideline on Treatments of Overweight or Obese Adults

The American College of Physicians (ACP) in July 2026 published its first living clinical guideline addressing pharmacologic management of overweight and obesity in nonpregnant adults in outpatient settings. The guidelines importance is driven by striking epidemiology: 59% of the global

Read Article

EBR Journal Club: Dapirolizumab Pegol in SLE (PHOENYCS GO)

The EBR Journal Club Companion applies my adapted version of the JAMA approach to critical appraisal to an important RCT in rheumatology. Each review covers four domains: Does this apply to my patients? What is the risk of bias? How great are the benefits and harms? And what didn’t they show me

Read Article

“ABCDE” Approach to Difficult-to-Treat Rheumatoid Arthritis

The proposed approach to difficult-to-treat rheumatoid arthritis is based on the EULAR definition (having failed 2 or more b/tsDMARDs). The authors provide guidance in the form of an easy acronym, A B C D E, which covers both diagnostic and therapeutic considerations.

Read Article

Sleep and Obesity: A Bidirectional Relationship

In July 2026, JAMA concisely reviewed the bidirectional relationship between sleep health and obesity. Obesity affects roughly 40% of US adults and sleep problems affect nearly one-third. This review outlines the biological mechanisms and clinical interventions relevant to weight management.

Read Article
Rheums! Do you have a Rheumatology question or case for Dr. Cush? Record it here, and we may feature it on an upcoming podcast. Tell us your name and where you practice rheumatology. https://t.co/LZ59KW8HdA https://t.co/DwHdvpTYax
Dr. John Cush @RheumNow( View Tweet )
Insights into Sjögren’s Disease - A Rheum Survey In August 2026, RheumNow surveyed rheumatologists about Sjogren’s disease (SjD) - how they approach diagnosis, treatment, and unique challenges; all important as new advances in SjD evolves. https://t.co/kCfCNl3xnW https://t.co/rhj3UL4JuM
Dr. John Cush @RheumNow( View Tweet )

NME: New Molecular Entities (8.28.2026)

Dr. Jack Cush reviews the news and journal articles from this past week on RheumNow.com. Take this week's RheumIQ and test your knowledge!

Read Article
Age-specific Incidence of Systemic Lupus Erythematosus Epidemiologic estimates on SLE diagnosis are limited. The CDC National Lupus Registry network of population-based SLE registries has assessed and reported age-specific incidence of SLE by sex, race, and ethnicity. https://t.co/g5A7DMQIyp
Dr. John Cush @RheumNow( View Tweet )
🆕 #AutoInflammatory / Periodic Fever Syndromes In Memory of Dr. Dan Kastner🕊️ So grateful Dr. Kastner agreed to review this graphic >1 year ago, providing thoughtful input and suggestions to improve the final version 🙏 New Board Review Series for Rheum OnePagers 📟 #RheumX https://t.co/zx8dX2yHkA
Mithu Maheswaranathan, MD @MithuRheum( View Tweet )
Rheum Scholarship (8.21.2026) Dr. Cush reviews the news and journal articles from this past week on RheumNow; talking about lumbar belts, scholarships and misdiagnosis. https://t.co/T6uggKb8n7 https://t.co/HJCMQqghaE
Dr. John Cush @RheumNow( View Tweet )
In the JAMA review of shoulder pain, what is the recommended first-line treatment for most shoulder diagnoses? Test your knowledge in this week's RheumIQ at https://t.co/TBlB4pmnKa https://t.co/mKClL2P0Tc
Dr. John Cush @RheumNow( View Tweet )
In rheumatoid arthritis, which RA-specific factor is the strongest modifiable driver of venous thromboembolism risk? Test your knowledge in this week's RheumIQ at https://t.co/TBlB4pmnKa. https://t.co/L69CPXWqfl
Dr. John Cush @RheumNow( View Tweet )

Rheum Scholarship (8.21.2026)

Dr. Cush reviews the news and journal articles from this past week on RheumNow.com; talking about lumbar belts, scholarships and misdiagnosis.

Read Article
"Great teachers set it up, and great students find the aha." - Seth Godin https://t.co/Fc3SPdsYCE

Dr. John Cush @RheumNow( View Tweet )

In 2026 Abbvie granted 34 scholarships to students With Inflammatory Diseases. In the last 10 yrs, theyve granted $6 million to >350 students in the US for higher education. These awards up to $20,000 per student renewable up to 4 yrs. https://t.co/DFy5SukB6G https://t.co/9mVkrhL2lo
Dr. John Cush @RheumNow( View Tweet )

Joint Pain Prevalence is not Declining

A current report from the national NHIS survey shows that over half of US adults diagnosed with arthritis reported moderate to severe joint pain.

Read Article

JAMA: Review of Shoulder Pain

Shoulder pain affects 16% of adults annually and is the third most common musculoskeletal presentation in primary care. This new review reframes the diagnostic and therapeutic approach, moving away from pathoanatomic labels (rotator cuff tendinopathy, impingement, bursitis) toward the umbrella

Read Article
JAMA has updated its guidance for the acceptable use of AI in authoring a Medical Publication. Despite growing AI use, very low rates of disclosure of AI use have been reported. This is about what is permitted & not permitted & what needs to be disclosed. https://t.co/zti0OnvBV0 https://t.co/6VHiEPGxUf
Dr. John Cush @RheumNow( View Tweet )
Updated Guidance for Artificial Intelligence Use in Medical Publications JAMA has updated its guidance for the acceptable use of artificial intelligence (AI) in authoring a medical publication. Despite growing AI use, very low rates of disclosure of AI use have been reported. https://t.co/irid5koIjo
Dr. John Cush @RheumNow( View Tweet )

Doubting RS3PE (8.14.2026)

Dr. Jack Cush reviews the news and journal articles this week where RheumNow featured info on cancer, deadly viruses, AI rules, poetry and good moons rising.

Read Article
2026 PGY1 match for non–US citizen international medical graduates (IMGs) has reached a 5-year low; yet US health care relies heavily on non–US-born MDs. In US, there are 6300 Rheumatologists - 46.9% US born USMG; 5.4% US born IMG; 11.2% non-US born USMG; 36.5% non-US born IMG https://t.co/cwx5ugBaVE
Dr. John Cush @RheumNow( View Tweet )

A Case of Sweet Syndrome

This overview appeared in JAMA Dermatology.

Read Article
×